Form 4 Forte Biosciences Inc For: 17 June
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Forte Biosciences Inc (FBRX)
The Forte Biosciences Inc share price today is 20.8200, view NASDAQ FBRX stock exchange data. Track the latest Forte Biosciences Inc share price with real-time updates on FBRX stock performance including market cap, day range, 52-week range and dividend yield. Access FBRX charts, earnings dates and analyst estimates to support your investment decisions.
20.8200
-1.4300(-6.43%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.2000
22.4800
52 wk Range
9.1000
35.7999
FBRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
20.200022.4800
52 wk Range
9.100035.7999
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
FBRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
63.7500
Upside
+206.20%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 8K Forte Biosciences Inc For: 14 May
- Investing.com
- Form 13G Forte Biosciences For: 8 June
- Investing.com
- Form 13G Forte Biosciences For: 13 May
- Investing.com
- Form S-3/A Forte Biosciences Inc For: 8 June
- Investing.com
- Form 4 Forte Biosciences Inc For: 17 June
- Investing.com
- Form 13G Forte Biosciences For: 8 June
- Investing.com
- Form S-3/A Forte Biosciences Inc For: 8 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 63.7500
(+206.20% Upside)
Earnings
Latest Release
11-05-2026
EPS / Forecast
-1.24 / -1.21
Revenue / Forecast
-- / --
Compare FBRX to Peers and Sector
Metrics to compare | FBRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFBRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.9x | −5.7x | −0.4x | |
PEG Ratio | −0.16 | −0.03 | 0.00 | |
Price/Book | 12.4x | 4.3x | 2.6x | |
Price / LTM Sales | - | 24.1x | 3.0x | |
Upside (Analyst Target) | 183.1% | 82.4% | 49.7% | |
Fair Value Upside | Unlock | −4.9% | 7.3% | Unlock |
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Forte Biosciences Inc (FBRX) Share Price Today?
The Forte Biosciences Inc share price today is 20.8200.
What is the current Forte Biosciences Inc (FBRX) share price and day range?
As of 08-07-2026, the Forte Biosciences Inc share price is 20.8200, with a previous close of 22.2500. The share price has ranged from 20.2000 to 22.4800 today, while the 52-week range spans from 9.1000 to 35.7999.
What Is the Forte Biosciences Inc Market Cap?
As of today, Forte Biosciences Inc market cap is 516.6900M.
What Is the Forte Biosciences Inc (FBRX) Share Price Target?
The average 12-month share price target for Forte Biosciences Inc is 63.7500, with a high estimate of 75 and a low estimate of 54. 5 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +206.20% Upside potential.
What Is Forte Biosciences Inc's Earnings Per Share (TTM)?
The Forte Biosciences Inc EPS (TTM) is -4.6459.
When Is the Next Forte Biosciences Inc Earnings Date?
Forte Biosciences Inc will release its next earnings report on 17-08-2026.
From a Technical Analysis Perspective, Is FBRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Forte Biosciences Inc Trade On?
Forte Biosciences Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Forte Biosciences Inc?
The stock symbol for Forte Biosciences Inc is "FBRX."
How Many Times Has Forte Biosciences Inc Stock Split?
Forte Biosciences Inc has split 2 times.
How Many Employees Does Forte Biosciences Inc Have?
Forte Biosciences Inc has 22 employees.
What Is the FBRX Premarket Price?
FBRX's last pre-market stock price is 22.8000. The pre-market share volume is 300.0000, and the stock has changed by 0.5500, or 2.4700%.
What Is the FBRX After Hours Price?
FBRX's last after hours stock price is 21.8203, the stock has changed by -0.4297, or -1.9300%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.